Drugs Associated with Weight Decreased Side Effect


Although all health products are carefully tested before they are licensed for sale, they can carry various risks. Some side effects may only become evident after a product is in use by the general population.

The following drugs are associated with Weight Decreased (click on the link below to view detailed reports):

Drug Name Weight Decreased Reports All Reports
Byetta 10046 119951
Humira 1628 272927
Avonex 802 158045
Enbrel 778 266818
Tysabri 689 196525
Victoza 669 18772
Remicade 662 88892
Forteo 604 61427
Chantix 494 102562
Nexium 456 64024
Rebif 427 61131
Lyrica 396 79654
Lipitor 341 48673
Revlimid 339 67826
Seroquel 317 83831
Duragesic 288 25668
Exenatide 285 3208
Crestor 283 41860
Lantus 269 26270
Incivek 260 22606
Pegasys 251 26383
Bydureon 244 5380
Xyrem 244 14347
Topamax 237 10175
Tecfidera 236 38299
Sutent 226 30373
Nexavar 220 35792
Zyprexa 219 36339
Januvia 211 17600
Fentanyl 200 26403
Fosamax 193 108140
Cymbalta 191 42505
Strattera 177 17277
Celebrex 168 33182
Betaseron 161 27282
Gilenya 152 32018
Abilify 150 20786
Mirena 132 95929
Victrelis 129 8169
Vyvanse 129 8560
1 of 50  View All


DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Weight Decreased Reports Submitted to FDA

The following Weight Decreased Side Effect Reports were submitted to FDA by healthcare professionals (physicians, pharmacists, and nurses), consumers (patients, family members, and lawyers) and manufacturers.

This information could help you understand how symptoms, such as Weight Decreased could occur, develop and what you can do about them.

Pyelonephritis, Oesophagitis Ulcerative, Weight Decreased

This is a report of a 40-year-old female patient (weight: NA) from FRANCE, suffering from the following symptoms/conditions: type 2 diabetes mellitus, who was treated with Byetta (dosage: 10 Ug, Bid, start time: Jan 23, 2012), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Pyelonephritis
  • Oesophagitis Ulcerative
  • Weight Decreased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Byetta treatment in female patients, resulting in Weight Decreased side effect. The patient was hospitalized.
Osteoarthritis, Abdominal Distension, Ovarian Epithelial Cancer, Weight Decreased, Change Of Bowel Habit

This report suggests a potential Humira Osteoarthritis, Abdominal Distension, Ovarian Epithelial Cancer, Weight Decreased, Change Of Bowel Habit side effect(s) that can have serious consequences. A 68-year-old female patient (weight: NA) from UNITED KINGDOM was diagnosed with the following symptoms/conditions: psoriasis and used Humira (dosage: 40 Mg Milligram(s), 2 Week, Subcutaneous) starting Mar 10, 2010. Soon after starting Humira the patient began experiencing various side effects, including:
  • Osteoarthritis
  • Abdominal Distension
  • Ovarian Epithelial Cancer
  • Weight Decreased
  • Change Of Bowel Habit
Drugs used concurrently:
  • Cyclosporine (150 Mg Milligram(s), 1 Day)
  • Amlodipine
  • Methotrexate (Dose Goes Up Or Down Depending On Severity)
Although Humira demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Weight Decreased, may still occur.
Weight Decreased

This Weight Decreased problem was reported by a consumer or non-health professional from UNITED STATES. A 55-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: multiple sclerosis. On Jul 28, 2010 this consumer started treatment with Avonex (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Avonex, the patient experienced the following unwanted symptoms/side effects:
  • Weight Decreased
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Weight Decreased, may become evident only after a product is in use by the general population.
Blood Pressure Increased, Cholecystectomy, Non-hodgkin's Lymphoma Stage I, Abdominal Pain Upper, Weight Decreased, Aggression, Vomiting, Immune System Disorder

This is a report of a 61-year-old patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: rheumatoid arthritis and was treated with Enbrel (dosage: 50 Mg, Qwk) starting Jan 01, 2011. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Blood Pressure Increased
  • Cholecystectomy
  • Non-hodgkin's Lymphoma Stage I
  • Abdominal Pain Upper
  • Weight Decreased
  • Aggression
  • Vomiting
  • Immune System Disorder
The patient was hospitalized. This opens a possibility that Enbrel treatment could cause the above reactions, including Weight Decreased, and some subjects may be more susceptible.
Insomnia, Abdominal Pain Upper, Weight Decreased, Hepatic Failure, Gastritis, Decreased Appetite, Fatigue, Depressed Mood

A 52-year-old female patient (weight: NA) from UNITED STATES with the following symptoms/conditions: multiple sclerosis started Tysabri treatment (dosage: NA) on Jan 21, 2010. Soon after starting Tysabri treatment, the subject experienced various side effects, including:
  • Insomnia
  • Abdominal Pain Upper
  • Weight Decreased
  • Hepatic Failure
  • Gastritis
  • Decreased Appetite
  • Fatigue
  • Depressed Mood
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Tysabri.
Weight Decreased, Nausea, Dyspepsia, Vomiting, Diarrhoea, Blood Glucose Fluctuation

A 58-year-old patient from US (weight: NA) experienced symptoms, such as: type 2 diabetes mellitus and was treated with Victoza(dosage: NA). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Weight Decreased
  • Nausea
  • Dyspepsia
  • Vomiting
  • Diarrhoea
  • Blood Glucose Fluctuation
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Victoza efficacy:
  • Lantus (39 U)
Weight Decreased, Hip Fracture, Dehydration

In this report, Remicade was administered for the following condition: crohn's disease.A consumer from CANADA (weight: NA) started Remicade treatment (dosage: NA) on Mar 30, 2004.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Weight Decreased
  • Hip Fracture
  • Dehydration
A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Remicade treatment could be related to the listed above side effect(s).
Weight Decreased, Emotional Distress, Tremor, Injection Site Injury, Injection Site Haemorrhage

This is a report of the following Forteo side effect(s):
  • Weight Decreased
  • Emotional Distress
  • Tremor
  • Injection Site Injury
  • Injection Site Haemorrhage
A female patient from BRAZIL (weight: NA) presented with the following condition: osteoporosis and received a treatment with Forteo (dosage: Unk, Qd) starting: Jan 01, 2007.The following concurrently used drugs could have generated interactions:
  • Calcium
  • Vitamin B3
This report suggests that a Forteo treatment could be associated with the listed above side effect(s).
Headache, Parosmia, Nausea, Vomiting, Weight Decreased, Decreased Appetite

This Chantix report was submitted by a female consumer from UNITED STATES (weight: NA). The patient was diagnosed with: tobacco user and Chantix was administered (dosage: 0.5 Mg, 1x/day) starting: May 01, 2009. The consumer developed a set of symptoms:
  • Headache
  • Parosmia
  • Nausea
  • Vomiting
  • Weight Decreased
  • Decreased Appetite
Other drugs used simultaneously:
  • Psyllium (Unk)
  • Bupropion (The Maximum Dose One Every Morning)
  • Oxycodone (Unk)
Those unexpected symptoms could be linked to a Chantix treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.
Intervertebral Disc Protrusion, Vomiting, Insomnia, Weight Decreased, Pain In Extremity

This is a report of a possible correlation between Nexium use and the following symptoms/side effect(s):
  • Intervertebral Disc Protrusion
  • Vomiting
  • Insomnia
  • Weight Decreased
  • Pain In Extremity
which could contribute to an assessment of Nexium risk profile.A 75-year-old female consumer from BRAZIL (weight: NA) was suffering from hiatus hernia and was treated with Nexium (dosage: NA) starting NS.Other concurrent medications:
  • Rabeprazole Sodium
The patient was hospitalized.
Decreased Appetite, Weight Decreased, Thrombocytopenic Purpura, Hypertension, Haemolytic Uraemic Syndrome, Renal Failure Acute, Pulmonary Oedema

A patient from UNITED KINGDOM (weight: NA) presented with the following symptoms: multiple sclerosis and after a treatment with Rebif (dosage: NA) experienced the following side effect(s):
  • Decreased Appetite
  • Weight Decreased
  • Thrombocytopenic Purpura
  • Hypertension
  • Haemolytic Uraemic Syndrome
  • Renal Failure Acute
  • Pulmonary Oedema
The treatment was started on Jan 01, 2007. Rebif was used in combination with the following drugs: NA.This report could alert potential Rebif consumers.
Weight Decreased

In this report, a female patient from UNITED STATES (weight: NA) was affected by a possible Lyrica side effect.The patient was diagnosed with pain. After a treatment with Lyrica (dosage: 75 Mg, 3x/day, start date: NS), the patient experienced the following side effect(s):
  • Weight Decreased
The following simultaneously used drugs could have led to this reaction:
  • Lisinopril (Unk)
  • Acetylsalicylic Acid (Unk)
  • Carvedilol (Unk)
  • Tramadol (Unk)
  • Metformin (Unk)
The findings here stress that side effects should be taken into consideration when evaluating a Lyrica treatment.
Weight Decreased, Fall, Rib Fracture, Clavicle Fracture

This is a report of a female patient from UNITED STATES (weight: NA), who used Lipitor (dosage: 10 Mg, Daily) for a treatment of blood cholesterol increased,hypertension,diabetes mellitus. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Weight Decreased
  • Fall
  • Rib Fracture
  • Clavicle Fracture
The following drugs could possibly have interacted with the Lipitor treatment
  • Lotrel (5/20 Mg, Daily)
  • Janumet
The patient was hospitalized.Taken together, these observations suggest that a Lipitor treatment could be related to side effect(s), such as Weight Decreased, Fall, Rib Fracture, Clavicle Fracture.
Asthenia, Weight Decreased, Abasia, Decreased Appetite

This Weight Decreased side effect was reported by a physician from UNITED STATES. A 59-year-old patient (weight:NA) experienced the following symptoms/conditions: multiple myeloma. The patient was prescribed Revlimid (dosage: 20 Mg, Days 1-21, Po), which was started on Aug 19, 2011. Concurrently used drugs:
  • Aspirin
  • Neurontin
  • Paxil
  • Dexamethasone
  • Flomax
  • Vitamin B12
When starting to take Revlimid the consumer reported the following symptoms:
  • Asthenia
  • Weight Decreased
  • Abasia
  • Decreased Appetite
The patient was hospitalized. These side effects may potentially be related to Revlimid.
Glossodynia, Oral Pain, Oral Herpes, Weight Decreased, Stomatitis

This is a Seroquel side effect report of a female patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: depression,sleep disorder,pancreatic carcinoma,dyspepsia, who was treated with Seroquel (dosage:200 Mg, Daily, start time: Apr 28, 2012), combined with:
  • Trazodone (5 Mg, As Needed)
  • Sutent (12.5 Mg, 3x/day)
  • Zantac (150 Mg, As Needed)
  • Celexa
  • Lexapro
  • Insulin (Unk)
  • Lexapro (40 Mg, Daily)
  • Sutent
, and developed a serious reaction and a Weight Decreased side effect. The patient presented with:
  • Glossodynia
  • Oral Pain
  • Oral Herpes
  • Weight Decreased
  • Stomatitis
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Seroquel treatment in female patients suffering from depression,sleep disorder,pancreatic carcinoma,dyspepsia, resulting in Weight Decreased.
Weight Decreased, Product Quality Issue, Dysuria, Concussion, Hypothalamo-pituitary Disorder, Fall, Memory Impairment

This report suggests a potential Duragesic-100 Weight Decreased side effect(s) that can have serious consequences. A female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): nerve injury,pain,movement disorder and used Duragesic-100 (dosage: NA) starting Mar 01, 2006. Soon after starting Duragesic-100 the patient began experiencing various side effects, including:
  • Weight Decreased
  • Product Quality Issue
  • Dysuria
  • Concussion
  • Hypothalamo-pituitary Disorder
  • Fall
  • Memory Impairment
Drugs used concurrently:
  • Percocet
  • Valium
  • Synthroid
  • Norditropin
Although Duragesic-100 demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Weight Decreased, may still occur.
Weight Decreased, Glycosylated Haemoglobin Increased, Blood Glucose Increased

This Weight Decreased problem was reported by a physician from UNITED KINGDOM. A 39-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): hyperglycaemia.On NS a consumer started treatment with Exenatide (dosage: 5 Ug, Bid). The following drugs/medications were being taken at the same time: NA. When commencing Exenatide, the patient experienced the following unwanted symptoms /side effects:
  • Weight Decreased
  • Glycosylated Haemoglobin Increased
  • Blood Glucose Increased
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Weight Decreased, may become evident only after a product is in use by the general population.
Diverticulitis, Vomiting, Weight Decreased, Food Intolerance, Abdominal Pain, Off Label Use

This is a Crestor side effect report of a 56-year-old patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: angina pectoris and was treated with Crestor (dosage: NA) starting NS. Concurrently used drugs:
  • Coreg
Soon after that, the consumer experienced the following of symptoms:
  • Diverticulitis
  • Vomiting
  • Weight Decreased
  • Food Intolerance
  • Abdominal Pain
  • Off Label Use
This opens a possibility that Crestor could cause Weight Decreased and that some patients may be more susceptible.
Weight Decreased, Hypoglycaemia

A 79-year-old patient (weight: NA) from UNITED STATES with the following symptoms: type 2 diabetes mellitus started Lantus treatment (dosage: NA) on NS. Soon after starting Lantus treatment, the consumer experienced several side effects, including:
  • Weight Decreased
  • Hypoglycaemia
. Concurrently used drugs:
  • Vitamin B-12
  • Folic Acid
  • Bystolic
  • Bystolic (5 Mg)
  • Aspirin
  • Glimepiride
  • Furosemide (40 Mg)
  • Carbidopa And Levodopa (25 Mg/100mg Tid)
This finding indicates that some patients can be more vulnerable to developing Lantus side effects, such as Weight Decreased.
Pollakiuria, Vomiting, Feeling Of Body Temperature Change, Nasal Congestion, Abdominal Pain, Weight Decreased, Decreased Appetite, Hyperhidrosis

This Weight Decreased side effect was reported by a consumer or non-health professional from . A patient (weight:NA) experienced the following symptoms/conditions: hepatitis c.The patient was prescribed Incivek (dosage: NA), which was started on Dec 19, 2011. Concurrently used drugs:
  • Pegasys
  • Ribavirin
.When starting to take Incivek the consumer reported symptoms, such as:
  • Pollakiuria
  • Vomiting
  • Feeling Of Body Temperature Change
  • Nasal Congestion
  • Abdominal Pain
  • Weight Decreased
  • Decreased Appetite
  • Hyperhidrosis
These side effects may potentially be related to Incivek.
Vomiting, Stress, Dehydration, Fatigue, Head Titubation, Weight Decreased

This is a report of a female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: hepatitis c,hypertension,irritable bowel syndrome, who was treated with Pegasys (dosage: NA, start time: Nov 01, 2011), combined with:
  • Diltiazem Hydrocholoride
  • Amitiza
  • Incivek
  • Ribavirin
  • Prevacid
  • Oxycontin
  • Levoxyl
  • Zofran
and developed a serious reaction and side effect(s). The consumer presented with:
  • Vomiting
  • Stress
  • Dehydration
  • Fatigue
  • Head Titubation
  • Weight Decreased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Pegasys treatment in female patients, resulting in Weight Decreased side effect. The patient was hospitalized.
Injection Site Induration, Weight Decreased, Injection Site Pain, Injection Site Warmth, Injection Site Rash, Headache, Nausea, Injection Site Mass, Injection Site Swelling

This report suggests a potential Bydureon Injection Site Induration, Weight Decreased, Injection Site Pain, Injection Site Warmth, Injection Site Rash, Headache, Nausea, Injection Site Mass, Injection Site Swelling side effect(s) that can have serious consequences. A 92-year-old female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus and used Bydureon (dosage: 2 Mg, Weekly (1/w)) starting Apr 01, 2012. Soon after starting Bydureon the patient began experiencing various side effects, including:
  • Injection Site Induration
  • Weight Decreased
  • Injection Site Pain
  • Injection Site Warmth
  • Injection Site Rash
  • Headache
  • Nausea
  • Injection Site Mass
  • Injection Site Swelling
Drugs used concurrently: NA. Although Bydureon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Weight Decreased, may still occur.
Insomnia, Weight Decreased, Memory Impairment, Loss Of Employment, Paranoia, Urinary Tract Infection, Legal Problem

This Insomnia, Weight Decreased, Memory Impairment, Loss Of Employment, Paranoia, Urinary Tract Infection, Legal Problem problem was reported by a consumer or non-health professional from UNITED STATES. A 35-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: cataplexy. On Apr 09, 2012 this consumer started treatment with Xyrem (dosage: 6 Gm (3 Gm,2 In 1 D),oral ; Oral ; 9 Gm (4.5 Gm,2 In 1 D),oral). The following drugs were being taken at the same time: NA. When commencing Xyrem, the patient experienced the following unwanted symptoms/side effects:
  • Insomnia
  • Weight Decreased
  • Memory Impairment
  • Loss Of Employment
  • Paranoia
  • Urinary Tract Infection
  • Legal Problem
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Weight Decreased, may become evident only after a product is in use by the general population.
Eye Pain, Cholelithiasis, Speech Disorder, Weight Decreased, Ocular Hyperaemia, Acne

This is a report of a 34-year-old patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: migraine and was treated with Topamax (dosage: 1 Once Day Po) starting Jan 01, 2010. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Eye Pain
  • Cholelithiasis
  • Speech Disorder
  • Weight Decreased
  • Ocular Hyperaemia
  • Acne
This opens a possibility that Topamax treatment could cause the above reactions, including Weight Decreased, and some subjects may be more susceptible.

A patient (weight: NA) from with the following symptoms/conditions: NA started treatment (dosage: NA) on NS. Soon after starting treatment, the subject experienced various side effects, including:
    Concurrently used drugs: NA. This finding indicates that some patients could be more vulnerable to .
    Weight Decreased, Chromaturia, Decreased Appetite, Hypothyroidism, Fatigue

    A patient from UNITED STATES (weight: NA) experienced symptoms, such as: renal cancer and was treated with Sutent(dosage: 50 Mg Daily X28 Days Q 42 Days). The treatment was initiated on Jan 01, 2012. After that a consumer reported the following side effect(s):
    • Weight Decreased
    • Chromaturia
    • Decreased Appetite
    • Hypothyroidism
    • Fatigue
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Sutent efficacy:
    • Lovenox (Unk)
    • Coumadin (Unk)
    • Metoprolol Succinate Extended Release (50 Mg, Unk)
    Hepatic Neoplasm Malignant, Dehydration, Fatigue, Cystitis, Asthenia, White Blood Cell Count Increased, Decreased Appetite, Weight Decreased, Convulsion

    In this report, Nexavar was administered for the following condition: hepatic neoplasm malignant.A 81-year-old consumer from UNITED STATES (weight: NA) started Nexavar treatment (dosage: 400 Mg, Bid) on May 21, 2012.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Hepatic Neoplasm Malignant
    • Dehydration
    • Fatigue
    • Cystitis
    • Asthenia
    • White Blood Cell Count Increased
    • Decreased Appetite
    • Weight Decreased
    • Convulsion
    A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Nexavar treatment could be related to the listed above side effect(s).
    Tooth Loss, Weight Decreased

    This is a report of the following Zyprexa side effect(s):
    • Tooth Loss
    • Weight Decreased
    A 50-year-old female patient from GERMANY (weight: NA) presented with the following condition: schizophrenia and received a treatment with Zyprexa (dosage: 20 Mg, Unk) starting: NS.The following concurrently used drugs could have generated interactions:
    • Tramadol Hcl
    • Lexotanil
    This report suggests that a Zyprexa treatment could be associated with the listed above side effect(s).
    Weight Decreased, Medical Device Complication, Loss Of Consciousness, Cardiac Pacemaker Insertion, Blood Glucose Decreased

    This Januvia report was submitted by a 84-year-old female consumer from UNITED STATES (weight: NA). The patient was diagnosed with: type 2 diabetes mellitus and Januvia was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
    • Weight Decreased
    • Medical Device Complication
    • Loss Of Consciousness
    • Cardiac Pacemaker Insertion
    • Blood Glucose Decreased
    Other drugs used simultaneously:
    • Lantus
    • Humulin R
    • Humulin N
    Those unexpected symptoms could be linked to a Januvia treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.
    Weight Decreased, Tachycardia, Fatigue, Skin Toxicity, Rash, Decreased Appetite, Infection, Arthralgia, Nausea

    This is a report of a possible correlation between Fentanyl use and the following symptoms/side effect(s):
    • Weight Decreased
    • Tachycardia
    • Fatigue
    • Skin Toxicity
    • Rash
    • Decreased Appetite
    • Infection
    • Arthralgia
    • Nausea
    which could contribute to an assessment of Fentanyl risk profile.A consumer from UNITED STATES (weight: NA) was suffering from pain management and was treated with Fentanyl (dosage: NA) starting Apr 20, 2012.Other concurrent medications:
    • Oxycodone Hcl
    • Compazine
    • Morphine
    • Temodar
    • Zelboraf
    • Megace
    • Zelboraf
    The patient was hospitalized.
    Bone Disorder, Device Failure, Depression, Rash, Osteopenia, Osteoarthritis, Gait Disturbance, Breast Disorder, Weight Decreased

    A 66-year-old female patient from UNITED STATES (weight: NA) presented with the following symptoms: osteoporosis,bone density decreased and after a treatment with Fosamax Plus D (dosage: NA) experienced the following side effect(s):
    • Bone Disorder
    • Device Failure
    • Depression
    • Rash
    • Osteopenia
    • Osteoarthritis
    • Gait Disturbance
    • Breast Disorder
    • Weight Decreased
    The treatment was started on Aug 26, 2008. Fosamax Plus D was used in combination with the following drugs:
    • Alendronate Sodium
    The patient was hospitalized and became disabled.This report could alert potential Fosamax Plus D consumers.
    Pneumonia, Staphylococcal Infection, Back Pain, Weight Decreased

    In this report, a female patient from UNITED STATES (weight: NA) was affected by a possible Cymbalta side effect.The patient was diagnosed with neuropathy peripheral,fibromyalgia,hypertension. After a treatment with Cymbalta (dosage: 60 Mg,daily, start date: NS), the patient experienced the following side effect(s):
    • Pneumonia
    • Staphylococcal Infection
    • Back Pain
    • Weight Decreased
    The following simultaneously used drugs could have led to this reaction:
    • Lyrica (225 Mg, 2x/day)
    • Lipitor (10 Mg,daily)
    • Norvasc (2.5 Mg,daily)
    • Gallamine Triethiodide (25 Mg,daily)
    • Celebrex
    • Levothyroxine (50 Ug,daily)
    • Hydrochlorothiazide (12.5mg, Daily)
    • Celebrex (200 Mg, 2x/day)
    The findings here stress that side effects should be taken into consideration when evaluating a Cymbalta treatment.
    Vomiting, Weight Decreased, Nausea

    This is a report of a female patient from UNITED STATES (weight: NA), who used Strattera (dosage: One Cap Qd Po) for a treatment of attention deficit/hyperactivity disorder. After starting a treatment on NS, the patient experienced the following side effect(s):
    • Vomiting
    • Weight Decreased
    • Nausea
    The following drugs could possibly have interacted with the Strattera treatment NA.Taken together, these observations suggest that a Strattera treatment could be related to side effect(s), such as Vomiting, Weight Decreased, Nausea.
    Gastritis, Gastric Ulcer, Aphagia, Abdominal Discomfort, Weight Decreased

    This Weight Decreased side effect was reported by a consumer or non-health professional from UNITED STATES. A 62-year-old female patient (weight:NA) experienced the following symptoms/conditions: back pain. The patient was prescribed Celebrex (dosage: 200 Mg, 2x/day), which was started on Jan 01, 2008. Concurrently used drugs: NA. When starting to take Celebrex the consumer reported the following symptoms:
    • Gastritis
    • Gastric Ulcer
    • Aphagia
    • Abdominal Discomfort
    • Weight Decreased
    These side effects may potentially be related to Celebrex.
    Weight Decreased, Pain In Extremity, Back Pain, Hypophagia, Bursitis, Depression, Musculoskeletal Pain

    This is a Betaseron side effect report of a 55-year-old female patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: multiple sclerosis, who was treated with Betaseron (dosage:8 Miu, Qod, start time: Aug 28, 2007), combined with: NA., and developed a serious reaction and a Weight Decreased side effect. The patient presented with:
    • Weight Decreased
    • Pain In Extremity
    • Back Pain
    • Hypophagia
    • Bursitis
    • Depression
    • Musculoskeletal Pain
    which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Betaseron treatment in female patients suffering from multiple sclerosis, resulting in Weight Decreased.
    Rash, Hyperhidrosis, Weight Decreased, Dermatitis Allergic, Dyspepsia

    This report suggests a potential Gilenya (fty) Capsule, 0.5mg Weight Decreased side effect(s) that can have serious consequences. A 43-year-old patient from US (weight:NA) was diagnosed with the following health condition(s): multiple sclerosis and used Gilenya (fty) Capsule, 0.5mg (dosage: 0.5 Mg, Qd, Oral) starting Apr 05, 2011. Soon after starting Gilenya (fty) Capsule, 0.5mg the patient began experiencing various side effects, including:
    • Rash
    • Hyperhidrosis
    • Weight Decreased
    • Dermatitis Allergic
    • Dyspepsia
    Drugs used concurrently:
    • Multivitamins (ascorbic Acid, Ergocalciferol, Folic Acid, Nicotinamide, Panthenol, Retinol, Riboflav
    Although Gilenya (fty) Capsule, 0.5mg demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Weight Decreased, may still occur.
    Depressive Symptom, Weight Decreased, Memory Impairment, Weight Increased, Mental Impairment, Dementia Alzheimer's Type, Cough

    This Weight Decreased problem was reported by a consumer or non-health professional from JAPAN. A 40-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): schizophrenia.On Jul 01, 2011 a consumer started treatment with Abilify (dosage: Df: 3mg And 1.5mg). The following drugs/medications were being taken at the same time: NA. When commencing Abilify, the patient experienced the following unwanted symptoms /side effects:
    • Depressive Symptom
    • Weight Decreased
    • Memory Impairment
    • Weight Increased
    • Mental Impairment
    • Dementia Alzheimer's Type
    • Cough
    Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Weight Decreased, may become evident only after a product is in use by the general population.
    Panic Attack, Weight Decreased, Decreased Appetite, Back Pain, Abdominal Pain, Anxiety, Depression

    This is a Mirena side effect report of a 34-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: menstrual disorder,contraception and was treated with Mirena (dosage: NA) starting Sep 01, 2011. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
    • Panic Attack
    • Weight Decreased
    • Decreased Appetite
    • Back Pain
    • Abdominal Pain
    • Anxiety
    • Depression
    The patient was hospitalized. This opens a possibility that Mirena could cause Weight Decreased and that some female patients may be more susceptible.
    Weight Decreased, Thrombocytopenia, Anaemia, Asthenia, Fatigue, Pallor

    A 48-year-old patient (weight: NA) from FRANCE with the following symptoms: hepatitis c started Victrelis treatment (dosage: 800 Mg;tid;po) on Sep 20, 2011. Soon after starting Victrelis treatment, the consumer experienced several side effects, including:
    • Weight Decreased
    • Thrombocytopenia
    • Anaemia
    • Asthenia
    • Fatigue
    • Pallor
    . Concurrently used drugs:
    • Truvada
    • Viraferonpeg (120 Mcg;qw;sc)
    • Rebetol (1200 Mg;bid;po, 800 Mg;bid;po)
    • Kaletra
    This finding indicates that some patients can be more vulnerable to developing Victrelis side effects, such as Weight Decreased.
    Weight Decreased, Vision Blurred, Decreased Appetite, Tourette's Disorder

    This Weight Decreased side effect was reported by a pharmacist from UNITED STATES. A 8-year-old patient (weight:NA) experienced the following symptoms/conditions: attention deficit/hyperactivity disorder.The patient was prescribed Vyvanse (dosage: 30 Mg), which was started on Jan 04, 2011. Concurrently used drugs: NA..When starting to take Vyvanse the consumer reported symptoms, such as:
    • Weight Decreased
    • Vision Blurred
    • Decreased Appetite
    • Tourette's Disorder
    These side effects may potentially be related to Vyvanse.

    Discuss Weight Decreased Side Effects